An Open-label, Multicenter, Randomized, 3 Arm Study of S-1 Compared With S-1/CDDP, or S-1/CDDP Compared With 5-FU/CDDP in Patients With Advanced Gastric Cancer Previously Untreated With Chemotherapy for Advanced Disease
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Response rate
every course for first three courses, then every other course
Jin Maolin, MD
Principal Investigator
Beijing Cancer Hospital
China: Food and Drug Administration
SC101
NCT00202969
July 2005
June 2007
Name | Location |
---|